| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-06-18 18:42:28 UTC |
|---|
| Update Date | 2019-07-23 07:14:50 UTC |
|---|
| HMDB ID | HMDB0060673 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 2,3-Dihydroxycarbamazepine |
|---|
| Description | 2,3-Dihydroxycarbamazepine belongs to the class of organic compounds known as dibenzazepines. Dibenzazepines are compounds with two benzene rings connected by an azepine ring. Azepine is an unsaturated seven-member heterocycle with one nitrogen atom replacing a carbon atom. In humans, 2,3-dihydroxycarbamazepine is involved in the carbamazepine metabolism pathway. 2,3-Dihydroxycarbamazepine is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on 2,3-Dihydroxycarbamazepine. |
|---|
| Structure | NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=C(O)C=C12 InChI=1S/C15H12N2O3/c16-15(20)17-11-4-2-1-3-9(11)5-6-10-7-13(18)14(19)8-12(10)17/h1-8,18-19H,(H2,16,20) |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C15H12N2O3 |
|---|
| Average Molecular Weight | 268.2674 |
|---|
| Monoisotopic Molecular Weight | 268.08479226 |
|---|
| IUPAC Name | 5,6-dihydroxy-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamide |
|---|
| Traditional Name | 5,6-dihydroxy-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=C(O)C=C12 |
|---|
| InChI Identifier | InChI=1S/C15H12N2O3/c16-15(20)17-11-4-2-1-3-9(11)5-6-10-7-13(18)14(19)8-12(10)17/h1-8,18-19H,(H2,16,20) |
|---|
| InChI Key | YITIUNLDWDJVSI-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dibenzazepines. Dibenzazepines are compounds with two benzene rings connected by an azepine ring. Azepine is an unsaturated seven-member heterocycle with one nitrogen atom replacing a carbon atom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzazepines |
|---|
| Sub Class | Dibenzazepines |
|---|
| Direct Parent | Dibenzazepines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Dibenzazepine
- Azepine
- 1-hydroxy-2-unsubstituted benzenoid
- Benzenoid
- Carbonic acid derivative
- Urea
- Azacycle
- Organopnictogen compound
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm √ó 2.1 mm; 1.7 Œºmparticle diameter). Predicted by Afia on May 17, 2022. | 3.96 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.4358 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.72 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1020.9 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 251.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 112.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 160.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 60.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 350.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 353.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 492.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 734.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 239.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1006.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 208.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 232.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 365.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 418.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 178.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 2,3-Dihydroxycarbamazepine,1TMS,isomer #1 | C[Si](C)(C)OC1=CC2=C(C=C1O)N(C(N)=O)C1=CC=CC=C1C=C2 | 2737.7 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,1TMS,isomer #2 | C[Si](C)(C)OC1=CC2=C(C=CC3=CC=CC=C3N2C(N)=O)C=C1O | 2740.6 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,1TMS,isomer #3 | C[Si](C)(C)NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=C(O)C=C21 | 2718.6 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,2TMS,isomer #1 | C[Si](C)(C)OC1=CC2=C(C=C1O[Si](C)(C)C)N(C(N)=O)C1=CC=CC=C1C=C2 | 2724.1 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,2TMS,isomer #2 | C[Si](C)(C)NC(=O)N1C2=CC=CC=C2C=CC2=CC(O[Si](C)(C)C)=C(O)C=C21 | 2662.5 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,2TMS,isomer #3 | C[Si](C)(C)NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=C(O[Si](C)(C)C)C=C21 | 2665.1 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,2TMS,isomer #4 | C[Si](C)(C)N(C(=O)N1C2=CC=CC=C2C=CC2=CC(O)=C(O)C=C21)[Si](C)(C)C | 2736.2 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TMS,isomer #1 | C[Si](C)(C)NC(=O)N1C2=CC=CC=C2C=CC2=CC(O[Si](C)(C)C)=C(O[Si](C)(C)C)C=C21 | 2701.7 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TMS,isomer #1 | C[Si](C)(C)NC(=O)N1C2=CC=CC=C2C=CC2=CC(O[Si](C)(C)C)=C(O[Si](C)(C)C)C=C21 | 2664.8 | Standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TMS,isomer #1 | C[Si](C)(C)NC(=O)N1C2=CC=CC=C2C=CC2=CC(O[Si](C)(C)C)=C(O[Si](C)(C)C)C=C21 | 3465.8 | Standard polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TMS,isomer #2 | C[Si](C)(C)OC1=CC2=C(C=C1O)N(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C1=CC=CC=C1C=C2 | 2704.3 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TMS,isomer #2 | C[Si](C)(C)OC1=CC2=C(C=C1O)N(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C1=CC=CC=C1C=C2 | 2874.9 | Standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TMS,isomer #2 | C[Si](C)(C)OC1=CC2=C(C=C1O)N(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C1=CC=CC=C1C=C2 | 3558.3 | Standard polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TMS,isomer #3 | C[Si](C)(C)OC1=CC2=C(C=CC3=CC=CC=C3N2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C1O | 2705.9 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TMS,isomer #3 | C[Si](C)(C)OC1=CC2=C(C=CC3=CC=CC=C3N2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C1O | 2880.3 | Standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TMS,isomer #3 | C[Si](C)(C)OC1=CC2=C(C=CC3=CC=CC=C3N2C(=O)N([Si](C)(C)C)[Si](C)(C)C)C=C1O | 3559.6 | Standard polar | 33892256 | | 2,3-Dihydroxycarbamazepine,4TMS,isomer #1 | C[Si](C)(C)OC1=CC2=C(C=C1O[Si](C)(C)C)N(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C1=CC=CC=C1C=C2 | 2742.8 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,4TMS,isomer #1 | C[Si](C)(C)OC1=CC2=C(C=C1O[Si](C)(C)C)N(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C1=CC=CC=C1C=C2 | 2899.0 | Standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,4TMS,isomer #1 | C[Si](C)(C)OC1=CC2=C(C=C1O[Si](C)(C)C)N(C(=O)N([Si](C)(C)C)[Si](C)(C)C)C1=CC=CC=C1C=C2 | 3385.9 | Standard polar | 33892256 | | 2,3-Dihydroxycarbamazepine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC2=C(C=C1O)N(C(N)=O)C1=CC=CC=C1C=C2 | 3000.1 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC2=C(C=CC3=CC=CC=C3N2C(N)=O)C=C1O | 2993.2 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=C(O)C=C21 | 2930.3 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC2=C(C=C1O[Si](C)(C)C(C)(C)C)N(C(N)=O)C1=CC=CC=C1C=C2 | 3193.0 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC(=O)N1C2=CC=CC=C2C=CC2=CC(O[Si](C)(C)C(C)(C)C)=C(O)C=C21 | 3106.8 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=C(O[Si](C)(C)C(C)(C)C)C=C21 | 3101.3 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N(C(=O)N1C2=CC=CC=C2C=CC2=CC(O)=C(O)C=C21)[Si](C)(C)C(C)(C)C | 3168.2 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)N1C2=CC=CC=C2C=CC2=CC(O[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C=C21 | 3310.2 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)N1C2=CC=CC=C2C=CC2=CC(O[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C=C21 | 3283.9 | Standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)N1C2=CC=CC=C2C=CC2=CC(O[Si](C)(C)C(C)(C)C)=C(O[Si](C)(C)C(C)(C)C)C=C21 | 3715.4 | Standard polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC2=C(C=C1O)N(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C1=CC=CC=C1C=C2 | 3362.2 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC2=C(C=C1O)N(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C1=CC=CC=C1C=C2 | 3415.1 | Standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1=CC2=C(C=C1O)N(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C1=CC=CC=C1C=C2 | 3737.7 | Standard polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC2=C(C=CC3=CC=CC=C3N2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1O | 3349.0 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC2=C(C=CC3=CC=CC=C3N2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1O | 3421.1 | Standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC1=CC2=C(C=CC3=CC=CC=C3N2C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1O | 3744.7 | Standard polar | 33892256 | | 2,3-Dihydroxycarbamazepine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC2=C(C=C1O[Si](C)(C)C(C)(C)C)N(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C1=CC=CC=C1C=C2 | 3589.6 | Semi standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC2=C(C=C1O[Si](C)(C)C(C)(C)C)N(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C1=CC=CC=C1C=C2 | 3664.3 | Standard non polar | 33892256 | | 2,3-Dihydroxycarbamazepine,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC2=C(C=C1O[Si](C)(C)C(C)(C)C)N(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C1=CC=CC=C1C=C2 | 3678.2 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 2,3-Dihydroxycarbamazepine GC-MS (Non-derivatized) - 70eV, Positive | splash10-00fr-0190000000-509be1694251c8235b8b | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 2,3-Dihydroxycarbamazepine GC-MS (2 TMS) - 70eV, Positive | splash10-00dj-4139000000-97a18e758ab55c5cd77d | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 2,3-Dihydroxycarbamazepine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 2,3-Dihydroxycarbamazepine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,3-Dihydroxycarbamazepine 10V, Positive-QTOF | splash10-014i-0090000000-42cebd081dc646351080 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,3-Dihydroxycarbamazepine 20V, Positive-QTOF | splash10-00or-0190000000-1ec3e2fe61df88b9088c | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,3-Dihydroxycarbamazepine 40V, Positive-QTOF | splash10-0a4m-1890000000-8b5812d17e9c9ece03b8 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,3-Dihydroxycarbamazepine 10V, Negative-QTOF | splash10-00r6-5090000000-40206d8a217ab805dc13 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,3-Dihydroxycarbamazepine 20V, Negative-QTOF | splash10-00di-2090000000-0a832a123ad5fdf58cd7 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,3-Dihydroxycarbamazepine 40V, Negative-QTOF | splash10-0006-9210000000-c0051afee3be9b00e7e8 | 2016-08-03 | Wishart Lab | View Spectrum |
|
|---|